Search research articles
Contact Us
Filters
Showing results (21-30 of 446) with videos related to
Page
of 45
Sort By:
Oncology Reports
|
October 20, 2017
In vitro and in vivo anti-primary effusion lymphoma activities of fucoidan extracted from Cladosiphon okamuranus Tokida
Chie Ishikawa, Naoki Mori
European Journal of Haematology
|
September 6, 2024
A New Strategy for Adult T-Cell Leukemia Treatment Targeting Glycogen Synthase Kinase-3β
Chie Ishikawa, Naoki Mori
Leukemia & Lymphoma
|
March 15, 2024
Inhibitory effect of a neddylation blockade on HTLV-1-infected T cells <i>via</i> modulation of NF-κB, AP-1, and Akt signaling
Chie Ishikawa, Naoki Mori
Bioscience, Biotechnology, and Biochemistry
|
February 12, 2021
Recent advances in chemical ecology: complex interactions mediated by molecules
Naoki Mori, Koji Noge
Oncology Reviews
|
May 21, 2015
Mechanisms of virus immune evasion lead to development from chronic inflammation to cancer formation associated with human papillomavirus infection
Masachika Senba, Naoki Mori
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
April 18, 2006
[Oncogenic mechanisms of KSHV]
Mariko Tomita, Naoki Mori
European Journal of Pharmacology
|
July 25, 2021
The antipsychotic drug pimozide is effective against human T-cell leukemia virus type 1-infected T cells
Chie Ishikawa, Naoki Mori
Oncology Letters
|
June 20, 2014
Abundant expression of HMGB1 in human T-cell lymphotropic virus type I-infected T-cell lines and high plasma levels of HMGB1 in patients with adult T-cell leukemia
Ryuichiro Kimura, Naoki Mori
European Journal of Haematology
|
June 24, 2020
MALT-1 as a novel therapeutic target for adult T-cell leukemia
Chie Ishikawa, Naoki Mori
Anticancer Research
|
October 28, 2025
Role of Ubiquitin-specific Protease 1 in the Pathogenesis and Treatment of Adult T-Cell Leukemia
Chie Ishikawa, Naoki Mori
Page
of 45
Search research articles
Search
Showing results (21-30 of 446) with videos related to
Sort By:
Page
of 45
Oncology Reports
|
October 20, 2017
In vitro and in vivo anti-primary effusion lymphoma activities of fucoidan extracted from Cladosiphon okamuranus Tokida
Chie Ishikawa, Naoki Mori
European Journal of Haematology
|
September 6, 2024
A New Strategy for Adult T-Cell Leukemia Treatment Targeting Glycogen Synthase Kinase-3β
Chie Ishikawa, Naoki Mori
Leukemia & Lymphoma
|
March 15, 2024
Inhibitory effect of a neddylation blockade on HTLV-1-infected T cells <i>via</i> modulation of NF-κB, AP-1, and Akt signaling
Chie Ishikawa, Naoki Mori
Bioscience, Biotechnology, and Biochemistry
|
February 12, 2021
Recent advances in chemical ecology: complex interactions mediated by molecules
Naoki Mori, Koji Noge
Oncology Reviews
|
May 21, 2015
Mechanisms of virus immune evasion lead to development from chronic inflammation to cancer formation associated with human papillomavirus infection
Masachika Senba, Naoki Mori
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
April 18, 2006
[Oncogenic mechanisms of KSHV]
Mariko Tomita, Naoki Mori
European Journal of Pharmacology
|
July 25, 2021
The antipsychotic drug pimozide is effective against human T-cell leukemia virus type 1-infected T cells
Chie Ishikawa, Naoki Mori
Oncology Letters
|
June 20, 2014
Abundant expression of HMGB1 in human T-cell lymphotropic virus type I-infected T-cell lines and high plasma levels of HMGB1 in patients with adult T-cell leukemia
Ryuichiro Kimura, Naoki Mori
European Journal of Haematology
|
June 24, 2020
MALT-1 as a novel therapeutic target for adult T-cell leukemia
Chie Ishikawa, Naoki Mori
Anticancer Research
|
October 28, 2025
Role of Ubiquitin-specific Protease 1 in the Pathogenesis and Treatment of Adult T-Cell Leukemia
Chie Ishikawa, Naoki Mori
Page
of 45